ROTAVIRUS VACCINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Rotavirus Vaccine Market, By Vaccine Type (Monovalent Vaccines (e.g., Rotarix) and Pentavalent Vaccines (e.g., RotaTeq)), By Strength (1 mL Oral Suspension and 2 mL Oral Solution), By Dosing Regimen (2-dose and 3-dose), By Patient Age Group (Infants (2-6 months), Preterm Infants, and Older Infants/Children (7 months and above)), By End User (Pediatric Hospitals, Pediatric Clinics, Vaccination Centers, Community Health Centers, and Academic and Research Institutions), By Distribution Channel (Public (Government) Distribution, Private Distribution, and International Agencies (e.g., UNICEF, Gavi, WHO procurement)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 15 Sep, 2025
Code: CMI8586
Pages: 168
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

The global rotavirus vaccine market is estimated to be valued at USD 2.51 Bn in 2025 and is expected to reach USD 4.47 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032. The global rotavirus vaccine market represents a critical segment of the pediatric immunization landscape, addressing one of the leading causes of severe diarrheal disease and childhood mortality worldwide. Rotavirus, a highly contagious virus, remains the primary etiological agent responsible for acute gastroenteritis in infants and young children under five years of age, particularly in developing nations where healthcare infrastructure and sanitation systems are inadequate.

The market encompasses various vaccine formulations, including live oral vaccines such as RotaTeq, Rotarix, and RotaVac, which have demonstrated significant efficacy in preventing severe rotavirus gastroenteritis and associated hospitalizations. The epidemiological burden of rotavirus infections, coupled with increasing healthcare awareness, expanding immunization programs, and growing government initiatives for childhood vaccination, has substantially driven market growth. The World Health Organization's recommendation for routine rotavirus vaccination in national immunization schedules has further accelerated market penetration across both developed and emerging economies. Additionally, the market benefits from continuous research and development activities focused on improving vaccine efficacy, safety profiles, and thermostability characteristics to enhance distribution in resource-limited settings with challenging cold-chain requirements.

Market Dynamics

The global rotavirus vaccine market is primarily driven by the substantial disease burden of rotavirus infections, which account for approximately 200,000 childhood deaths annually worldwide, creating urgent demand for effective preventive interventions. Government-led immunization initiatives, supported by international organizations like GAVI Alliance and WHO, have significantly expanded vaccine accessibility through funding mechanisms and policy recommendations that encourage routine rotavirus vaccination integration into national immunization programs. The growing awareness among healthcare professionals and parents regarding the severe complications associated with rotavirus gastroenteritis, including dehydration, hospitalization, and potential mortality, continues to fuel market adoption rates across diverse geographical regions.

However, the market faces considerable restraints including high vaccine costs that limit accessibility in low-income countries, complex cold-chain storage requirements that pose logistical challenges in remote areas with inadequate infrastructure, and safety concerns related to intussusception risks, particularly following RotaShield withdrawal, which has created lingering hesitancy among some healthcare providers and parents. Religious and cultural barriers in certain communities also impede vaccination uptake, while regulatory complexities and lengthy approval processes slow market entry for new vaccine formulations. Despite these challenges, significant opportunities emerge from expanding healthcare infrastructure in developing nations, increasing birth rates in emerging economies, and growing medical tourism that enhances vaccine accessibility. Technological advancements in vaccine development, including thermostable formulations that reduce cold-chain dependency, present substantial market expansion potential.

Key Features of the Study

This report provides in-depth analysis of the global rotavirus vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global rotavirus vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc and Merck & Co., Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global rotavirus vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rotavirus vaccine market

Market Segmentation

Vaccine Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monovalent Vaccines (e.g., Rotarix)
- Pentavalent Vaccines (e.g., RotaTeq)
Strength Insights (Revenue, USD Bn, 2020 - 2032)
- 1 mL Oral Suspension
- 2 mL Oral Solution
Dosing Regimen Insights (Revenue, USD Bn, 2020 - 2032)
- 2-dose
- 3-dose
Patient Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Infants (2-6 months)
- Preterm Infants
- Older Infants/Children (7 months and above)
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Hospitals
- Pediatric Clinics
- Vaccination Centers
- Community Health Centers
- Academic and Research Institutions
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Public (Government) Distribution
- Private Distribution
- International Agencies (e.g., UNICEF, Gavi, WHO procurement)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- GlaxoSmithKline plc
- Merck & Co., Inc.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Rotavirus Vaccine Market, By Vaccine Type
  - Global Rotavirus Vaccine Market, By Strength
  - Global Rotavirus Vaccine Market, By Dosing Regimen
  - Global Rotavirus Vaccine Market, By Patient Age Group
  - Global Rotavirus Vaccine Market, By End User
  - Global Rotavirus Vaccine Market, By Distribution Channel
  - Global Rotavirus Vaccine Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
Global Rotavirus Vaccine Market, By Vaccine Type, 2020-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Monovalent Vaccines (e.g., Rotarix)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pentavalent Vaccines (e.g., RotaTeq)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Rotavirus Vaccine Market, By Strength, 2020-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- 1 mL Oral Suspension
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 2 mL Oral Solution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Rotavirus Vaccine Market, By Dosing Regimen, 2020-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- 2-dose
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 3-dose
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Rotavirus Vaccine Market, By Patient Age Group, 2020-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Infants (2-6 months)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Preterm Infants
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Older Infants/Children (7 months and above)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Rotavirus Vaccine Market, By End User, 2020-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Pediatric Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatric Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vaccination Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Community Health Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutions
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Rotavirus Vaccine Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Public (Government) Distribution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Private Distribution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- International Agencies (e.g., UNICEF, Gavi, WHO procurement)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Rotavirus Vaccine Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Dosing Regimen, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Dosing Regimen, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Dosing Regimen, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Dosing Regimen, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Dosing Regimen, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Dosing Regimen, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About Us

*Browse 32 market data tables and 28 figures on ‘Rotavirus Vaccine Market' - Global forecast to 2032

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now